Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer

A Damera, A J Evans, E J Cornford, A R M Wilson, H C Burrell, J J James, S E Pinder, I O Ellis, A H S Lee, R D Macmillan, A Damera, A J Evans, E J Cornford, A R M Wilson, H C Burrell, J J James, S E Pinder, I O Ellis, A H S Lee, R D Macmillan

Abstract

The purpose of this study was to examine the use of ultrasound (US)-guided core biopsy of axillary nodes in patients with operable breast cancer. The ipsilateral axillae of 187 patients with suspected primary operable breast cancer were scanned. Nodes were classified based on their shape and cortical morphology. Abnormal nodes underwent US-guided core biopsy/fine needle aspiration (FNA), and the results correlated with subsequent axillary surgery. The nodes were identified on US in 103 of 166 axillae of patients with confirmed invasive carcinoma. In total, 54 (52%) met the criteria for biopsy: 48 core biopsies (26 malignant, 20 benign node, two normal) and six FNA were performed. On subsequent definitive histological examination, 64 of 166 (39%) had axillary metastases. Of the 64 patients with involved nodes at surgery, preoperative US identified nodes in 46 patients (72%), of which 35 (55%) met the criteria for biopsy and 27 (42%) of these were diagnosed preoperatively by US-guided biopsy. In conclusion, US can identify abnormal nodes in patients presenting with primary operable breast cancer. In all, 65% of these nodes are malignant and this can often be confirmed with US-guided core biopsy.

Figures

Figure 1
Figure 1
Surgical histology and preoperative US core biopsy results. n=no. of patients; hist−=no malignant nodes on surgical histology; hist+=malignant nodes on surgical histology; stage 1=no positive nodes; stage 2=1 – 3 positive nodes; stage 3=4 or more positive nodes; US node+=nodes seen on US; US node−=no nodes seen on US; USB=US core biopsy performed; no USB=US core biopsy not carried out as nodes did not meet our criteria for biopsy: M=malignant; B=benign; SE=sampling error.

References

    1. Bonnema J, van Geel AN, van Ooijen B, Mali SPM, Tjiam LS, Henzen-Logmans SC, Schmitz PIM, Wiggers T (1997) Ultrasound guided aspiration biopsy for detection of non palpable axillary node metastases in breast cancer patients: New diagnostic method. World J Surg 21: 270–274
    1. Britton PD, McCann J (1999) Needle biopsy in the NHS Breast Screening Programme 1996/1997: how much and how accurate? Breast 8: 5–11
    1. Bruneton JN, Caramella E, Hery M, Aubanel D, Manzino JJ, Picard JL (1986) Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 158: 325–326
    1. De Kanter AY, van Eijck CHJ, van Geel AN, Kruijt RH, Henzen SC, Paul MA, Eggermont AMM, Wiggers T (1999) Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 86: 1459–1462
    1. Duff M, Hill AD, Mc Greal G, Walsh S, Mc Dermott EW, O'Higgins NJ (2001) Prospective evaluation of the morbidity of axillary clearance. Br J Surg 88(6): 891
    1. Dupont EL, Kamath VJ, Ramnath VM, Shivers SC, Cox C, Berman C, Leight Jr GS, Ross MI, Blumencranz P, Reintgen DS, DOD Breast Lymphatic Mapping Trial Investigators (2001) The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol 8(4): 354–360
    1. Feu J, Tresserra F, Fabregas R, Navarro B, Grases PJ, Suris JC, Fernandez-Cid A, Alegret X (1997) Metastatic breast carcinoma in axillary lymph nodes: In vitro US detection. Radiology 205: 831–835
    1. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER (1983) Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 52: 1551–1557
    1. de Freitas Jr R, Costa MV, Schneider SV, Nicolau MA, Marussi E (1991) Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 17: 240–244
    1. Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R, Micheli A, Asero S, Ferraris C, Gennaro M, Bombardieri E, Cascinelli N (2001) Axillary lymph node staging in breast cancer by 2-fluro 2-deoxy D-glucose positron emission tomography: clinical evaluation and alternate management. J Natl Cancer Inst 93(21): 1659–1661
    1. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT (1992) Assessment of morbidity from complete axillary dissection. Br J Surg 77: 760–764
    1. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P (1998) The sentinel node in breast cancer: a multicenter validation study. New Eng J Med 339(14): 941–946
    1. Krishnamurthy S, Sneige N, Bedi DG, Edeiken BS, Fornage BD, Kuerer H M, Singletary SE, Hunt KK (2002) Role of ultrasound guided fine needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95: 982–987
    1. Lambah A, Dixon JM, Prescott RJ, Jack W, Forrest AM, Rodger A, Chetty U (2001) Randomised study of axillary clearance versus four node sampling. Eur J Cancer 37(Suppl 5): 2
    1. Lumachi F, Ferretti G, Povolato M, Marzola MC, Zucchetta P, Geatti O, Bui F, Brandes AA (2001) Usefulness of 99m-Tc Sestamibi scintigraphy in suspected breast cancer and in axillary lymph node metastases detection. Eur J Surg Oncol 27: 256–259
    1. March DE, Wechsler RJ, Kurtz AB, Rosenberg AL, Needleman L (1991) CT-pathologic correlation of axillary lymph nodes in breast carcinoma. J Comput Assist Tomogr 15: 440–444
    1. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Hasegawa Y, Noguchi S, Koyama H (2001) Gamma probe and ultrasonographically guided fine needle aspiration biopsy of sentinel lymph nodes in breast cancer patients. Eur J Surg Oncol 27: 141–145
    1. Murray AD, Staff RT, Redpath TW, Gilbert FJ, Ah-See AK, Brookes JA, Miller ID, Payne S (2002) Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes. Br J Radiol 75(891): 220–228
    1. O'Rourke S, Galea MH, Morgan D, Euhus D, Pinder S, Ellis IO, Elston CW (1994) Local recurrence after simple mastectomy. Br J Surg 81(3): 386–389
    1. Rampaul RS, Mullinger K, Macmillan RD, Cid J, Holmes S, Morgan DAL, Blamey R. Incidence of clinically significant lymphaedema as a complication following surgery for primary operable breast cancer. Eur J Cancer, (in press)
    1. Uematsu T, Muneaki S, Keiichi H (2001) In vitro high resolution helical CT of small axillary lymph nodes in patients with breast cancer: correlation of CT and histology. Am J Roentgenol 176: 1069–1074
    1. Vaidya JS, Vyas JJ, Thakur MJ, Khandelwal KC, Mitra I (1996) Role of ultrasonography to detect axillary node involvement in operable breast cancer. Eur J Surg Oncol 22: 140–143
    1. Vassallo P, Wernrcke K, Roos N, Peters PE (1992) Differentiation of benign from malignant superficial lymphadenopathy: the role of high resolution US. Radiology 183: 215–222
    1. Verbanck J, Vandewiele I, De Winter H, Tytgat J, Van Aelst F, Tanghe W (1997) Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: a prospective study in 144 consecutive patients. J Clin Ultrasound 25: 53–56
    1. Wahl RL (2001) Current status of PET in breast cancer imaging, staging and therapy. Semin Roentgenol 36: 250–260
    1. Yang WT, Chang J, Metreweli C (2000) Patients with breast cancer: differences in colour Doppler flow and gray scale ultrasound features of benign and malignant axillary nodes. Radiology 215: 568–573
    1. Yang WT, Metreweli C, Lam PKW, Chang J (2001) Benign and malignant breast masses and axillary nodes: evaluation with echo-enhanced colour power Doppler ultrasound. Radiology 220: 795–802
    1. Yoshimura G, Sakurai T, Oura S, Suzuma T, Tamaki T, Umemura T, Kokawa Y, Yang Q (1999) Evaluation of axillary lymph node status in patients with MRI. Breast Cancer 6: 249–258

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere